As of June 30, 2023, Biocartis Group N.V. has 93.92M shares outstanding.
| Shares Outstanding | 93.92M |
These figures are as of June 30, 2023.
| PB Ratio | -0.63 |
| P/TBV Ratio | -0.58 |
As of June 30, 2023, Biocartis Group N.V. maintains a current ratio of 2.15, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.15 |
| Quick Ratio | 0.78 |
| Debt / Equity | -282.01 |
As of the close on October 20, 2023, Biocartis Group N.V.'s stock has declined approximately 77.17% over the past 52 weeks. The 50-day moving average sits at 0.31, while the 200-day moving average is 0.49.
| 52-Week Price Change | -77.17% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.49 |
Biocartis Group N.V.'s most recent stock split took place on November 17, 2022 with a 500:573 split ratio.
| Last Split Date | 11/17/2022 |
| Split Ratio | 500:573 |
As of June 30, 2023, Biocartis Group N.V. has an Altman Z-Score of -5.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5.59 |
Already premium?